Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 3, 2002, Pages 279-284

  Fokkens, Wytske J ^a   Cserháti, Endre ^b   Lopes dos Santos, José Manuel ^c   Praca, Fatima ^d   Van Zanten, Marinus ^e   Schade, Alexander ^f   Simon, György ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c HOSPITAL PEDRO HISPANO   (Portugal)

^d CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^e TWENTEBORG HOSPITAL   (Netherlands)

^f MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CETIRIZINE; NOSE SPRAY; PLACEBO;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC RHINITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CYTOLOGY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EOSINOPHIL; EPISTAXIS; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE AIRFLOW; NOSE SECRETION; PEAK NASAL INSPIRATORY FLOW; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; STEROID THERAPY; VALIDATION PROCESS; VIRUS INFECTION;

EID: 0036769517     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61955-2     Document Type: Article

References (26)

1. Rachelefsky GS, Goldberg M, Katz RM, et al. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1978;61:310-314.
2. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994;49(Suppl):1-34.
3. 1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-1629.
4. Creticos P, Fireman P, Settipane G, et al. Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group. Allergy Asthma Proc 1998;19:285-294.
5. Fisher WG. Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children. Ann Allergy 1994;73:515-520.
6. Andersson M, Berglund R, Greiff L, et al. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis. Rhinology 1995;33:18-21.
7. Stern MA, Wade AG, Ridout SM, Cambell LM. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann Allergy Asthma Immunol 1998;81:354-358.
8. Day J, Carrillo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol 1998;102:902-908.
9. Meltzer EO. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 1998;81:128-134.
10. Juniper EF, Howland WC, Roberts NB, et al. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998;101:163-170.
11. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivifis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-423.
12. Godthelp T, Holm AF, Fokkens WJ, et al. Dynamics of nasal eosinophils in response to a nonnatural allergen challenge in patients with allergic rhinitis and control subjects: a biopsy and brush study. J Allergy Clin Immunol 1996;97:800-811.
13. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
14. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2000;85:111-114.
15. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-134.
16. Agertoft L, Pedersen S. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. J Allergy Clin Immunol 1999;104:948-952.
17. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000;343:1064-1069.
18. Passalacqua G, Albano M, Canonica GW, et al. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000;55:16-33.
19. Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121-126.
20. Juniper EF. Quality of life in adults and children with asthma and rhinitis. Allergy 1997;52:971-977.
21. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998;101:633-637.
22. Holmstrom M, Scadding GK, Lund VJ, Darby YC. Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 1990;28:191-196.
23. Gleeson MJ, Youlten LJ, Shelton DM, et al. Assessment of nasal airway patency: a comparison of four methods. Clin Otolaryngol 1986;11:99-107.
24. Prescott CA, Prescott KE. Peak nasal inspiratory flow measurement: an investigation in children. Int J Pediatr Otorhinolaryngol 1995;32:137-141.
25. Pickering DN, Beardsmore CS. Nasal flow limitation in children. Pediatr Pulmonol 1999;27:32-36.
26. Day JH, Briscoe MP, Rafeiro E, et al. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol 2000;105:489-494.